23Sep 2021
Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review

Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review

Ibuprofen is included on websites and frequently referenced lists as medium risk for inducing hemolysis in children with glucose‐6‐phosphate dehydrogenase (G6PD) deficiency. This is a challenge for otolaryngologists who perform tonsillectomy and other surgeries in children, as ibuprofen serves as an important alternative to opioids for perioperative pain control. We systematically review published literature and national medication databases to evaluate the risk of hemolytic anemia and related complications when ibuprofen is used in children with G6PD deficiency. There was no evidence of hemolysis from perioperative exposure to ibuprofen or other NSAIDs in children with G6PD deficiency at high risk. There is scant, low‐quality evidence of hemolytic anemia caused by ibuprofen in children with G6PD deficiency. Drug‐induced hemolytic anemias are recognizable and reversible following discontinuation of the inciting medication.

  • #ent

Like

Save

Share